Niche leader in real-time AI-enabled ISR subscriptions (Assured model, 35cm Gen-3 imagery, Spectra AI analytics) for defense/intel customers. Not the broadest EO platform — Planet Labs has more coverage breadth and is further along the profitability curve; Maxar holds deeper classified-program incumbency. BlackSky's moat is the combination of rapid-revisit tasked access plus embedded analytics at a resolution tier competitors have not commercially matched. The ceiling risk is real: at $107M consolidated revenue in a market where Planet exceeds $300M annualized, BlackSky is a good-pond/adequate-fish play — genuinely differentiated in its niche but not the sector's dominant force.

| Metric | Value | |--------|-------| | Ticker | BKSY (NYSE) | | Price | $44.81 | | Market cap | $1.57B | | FY2025 revenue | $106.6M | | FY2025 net loss | -$70.3M | | FY2025 OCF | -$28.3M | | FY2025 cash | $42.4M | | Shares outstanding | 36.8M (as of March 31, 2026) | | Rating | 4.8 / 10 — Mixed (YELLOW) |

---

BlackSky Technology operates a commercial satellite constellation providing real-time geospatial intelligence. Its Gen-3 satellites (35cm very-high-resolution imagery, onboard AI processing) are tasked on-demand rather than flying fixed orbits and collecting opportunistically. The core commercial product is the Assured subscription: guaranteed priority tasking windows, rapid-revisit access, and embedded Spectra AI analytics delivered as a software-layer on top of the imagery feed.

Customers are primarily defense and intelligence agencies — U.S. government vehicles (NGA, NRO, Space Force) plus a growing international defense base. The company also historically ran a Mission Solutions segment (systems integration work for government) that is now in sharp decline and generating negative gross margins.

Four Gen-3 satellites were operational as of March 2026. A fifth was ready for shipment at the Q1 2026 call; management targets eight on-orbit by December 2026.

---

The strategic pivot is from a mixed imagery-and-services business toward a pure subscription model:

1.

Constellation build-out: Scale from 4 to 8+ Gen-3 satellites by end-2026, expanding Assured subscription capacity and enabling higher revisit rates that justify premium pricing. 2.

Subscription run-rate: Hit $100M annual run-rate on space-based intelligence and AI services (the high-margin segment) by late 2026. This segment carried approximately 80% gross margins per management's Q1 2026 statements. 3.

Mission Solutions wind-down: The legacy integration segment had $2.0M revenue in Q1 2026 at deeply negative gross margins. Management has provided no formal restructuring timeline. 4.

International expansion: International defense customers now constitute a growing majority of new contract wins. The $30M one-year Assured contract (management's largest single-year Assured deal) and $25M multi-year Ministry of Defense deal, both announced in 2026, establish the land-and-expand playbook internationally. 5.

AFRL next-generation payload: A $99M sole-source IDIQ from the Air Force Research Lab (awarded March 2026) funds development of an advanced large-aperture EO payload with on-orbit AI processing — a next-generation capability investment on top of Gen-3.

---

Revenue history (SEC EDGAR, confirmed)

| FY | Revenue | |----|--------| | 2020 | $21.1M | | 2021 | $34.1M | | 2022 | $65.4M | | 2023 | $94.5M | | 2024 | $102.1M | | 2025 | $106.6M |

FY2025 growth slowed to 4.4% YoY as the Mission Solutions segment contracted. The $130-150M FY2026 guidance implies 22-41% growth — which would be the best annual growth rate since FY2023.

Operating income

| FY | Operating income | |----|------------------| | 2022 | -$86.5M | | 2023 | -$56.0M | | 2024 | -$44.3M | | 2025 | -$46.9M |

The multi-year leverage trend (FY2022 to FY2024) stalled and slightly reversed in FY2025 (-$46.9M vs. -$44.3M in FY2024).

Net income

| FY | Net income | |----|------------| | 2023 | -$53.9M | | 2024 | -$57.2M | | 2025 | -$70.3M |

Net losses are widening in absolute dollars year-over-year, driven by growing depreciation on new satellites and $15M annual interest on the 8.25% convertible notes.

Operating cash flow

| FY | OCF | |----|-----| | 2022 | -$44.5M | | 2023 | -$17.4M | | 2024 | -$6.4M | | 2025 | -$28.3M |

The improving trend through FY2024 sharply reversed in FY2025 — a $21.9M deterioration year-over-year.

Balance sheet & runway

-

FY2025 cash: $42.4M -

Q1 2026 cash + short-term investments: $117.5M (reflecting proceeds from the $160M convertible notes offering) -

Total debt (Q1 2026): Approximately $209M, comprising $185M in 8.25% convertible notes due 2033 and satellite launch vendor financing -

Annual interest cost: Approximately $15M (8.25% on $185M notes) -

FY2026 CapEx guidance: $50-60M -

Net debt: Approximately $92M (Q1 2026 cash/investments of $117.5M vs. $209M debt) -

Runway: At guided $12-24M adjusted EBITDA and $50-60M CapEx, free cash flow remains materially negative through end-2026 at minimum. The Q1 2026 cash position covers approximately 2-3 years at the current burn rate, but a further capital raise before GAAP profitability is plausible.

Share count & dilution

| Date | Shares | |------|--------| | Dec 2024 | 30.7M | | Dec 2025 | 35.9M | | Mar 2026 | 36.8M |

Share count increased 19.9% in roughly 15 months post-split. Additional dilution sources: (1) $185M convertible notes with a $36.78 conversion price (in-the-money at current ~$44.81 stock price), implying approximately 5M potential new shares (~14% dilution on current 36.8M outstanding); (2) an active ATM equity shelf authorized for additional issuances per the May 2026 424B5 filing. Further dilution before free cash flow breakeven is likely.

---

-

Trailing P/S: $1.57B market cap / $106.6M FY2025 revenue = 14.7x -

Forward P/S: $1.57B / $140M guidance midpoint = 11.2x -

Peer comparison: Planet Labs (PLNT), at a larger revenue scale and already EBITDA/FCF positive, trades at approximately 5-7x forward revenue (analyst estimates, not from the fact sheet). BlackSky carries a stage premium for the subscription inflection thesis.

Fair-value range: Using a blended forward revenue multiple of 8-12x on FY2026 guidance midpoint ($140M) — 8x reflecting downside if H2 execution disappoints (aligning toward the Planet Labs comparator's multiple), 12x reflecting successful subscription inflection re-rating — implies a range of approximately $30-42 per share on current share count. This is a P/S-based range, not a DCF, and is highly sensitive to execution. The current price ($44.81) sits modestly above the top of this range, suggesting the market is pricing the bull case rather than the base case.

*Methodology: forward P/S on FY2026 revenue guidance midpoint ($140M), 8x bear/12x bull multiple range vs. peer Planet Labs and a stage premium for first-EBITDA-positive inflection. All figures from confirmed sources.*

Jefferies downgraded to Hold in May 2026, explicitly citing 'general space sector enthusiasm drove stock appreciation rather than fundamental improvements.'

---

Six sell-side analysts cover BKSY (Jefferies, Oppenheimer, Canaccord among them) per stockanalysis.com. No promotion signals detected — coverage is institutional-grade. The company files timely 10-Ks and 10-Qs with the SEC; the Q1 2026 10-Q was filed May 7, 2026.

Persistent equity dilution via compensation programs and ATM shelf issuances. The convertible note overhang (~5M potential shares at $36.78 conversion price, in-the-money at $44.81) is fully disclosed in SEC filings. No buyback program. Insider ownership specifics are not available in the fact sheet reviewed.

---

The bull thesis is a business model mix-shift re-rating, not a cheap-stock thesis. The market still prices BKSY on blended revenue that includes a dying Mission Solutions drag; the subscription segment — which is growing above 50% YoY and carries approximately 80% gross margins — is the real business. At the $100M subscription run-rate target (targeted late 2026), the effective P/S on the high-margin segment compresses sharply while adjusted EBITDA (guided $12-24M) turns positive for the first time.

The contract wins are real and large: $200M ceiling NGA Luno B IDIQ, $99M sole-source AFRL IDIQ, $25M multi-year international Ministry of Defense Assured deal, $30M one-year international Assured deal (management's largest single-year Assured contract ever, converted from a six-figure pilot in under six months). The '$30M from a six-figure pilot in under six months' data point is the most important: it validates the land-and-expand playbook at scale and speed.

If the subscription run-rate inflects and the stock re-rates from 'pre-profitability satellite operator' to 'defense-tech SaaS,' the multi-year upside is meaningful. Realistic near-term upside on clean execution: 7-25% (base case re-rate to 12-14x forward). The larger option-value case (Palantir-style defense-SaaS multiple, 20-30x revenue) requires 3-4 years of sustained operational delivery not yet demonstrated.

---

1. H2 2026 back-half loading is the single largest risk. Q1 2026 revenue was $20.8M; reaching the $140M guidance midpoint requires approximately $39.7M average per quarter for Q2-Q4 — a 91% sequential increase from Q1. This is the company's most extreme H2 loading in its public history. Mission Solutions roll-off is one factor, but the space intelligence segment itself needs to nearly double sequential revenue. One quarter's delay on a large government deal breaks the year.

2. Operating cash flow reversed sharply. FY2024 OCF was -$6.4M (approaching breakeven); FY2025 OCF was -$28.3M — a $21.9M deterioration in one year. With $50-60M CapEx guided and $15M annual interest, free cash flow will remain deeply negative through at least end-2026.

3. Net losses widening. Net loss: FY2023 -$53.9M, FY2024 -$57.2M, FY2025 -$70.3M. Losses are growing faster than revenue. Even if adjusted EBITDA turns positive as guided, GAAP net loss will remain deep negative due to constellation depreciation and interest expense.

4. Debt vs. cash. $185M in 8.25% convertible notes (due 2033) plus satellite vendor financing totaling approximately $209M in debt, against $42.4M year-end FY2025 cash (improved to $117.5M cash + investments at Q1 2026 from the notes raise). Net debt approximately $92M at Q1 2026.

5. Convertible and ATM dilution overhang. The $36.78 conversion price is below the current $44.81 stock price — in-the-money conversion would add approximately 5M shares (~14% dilution on 36.8M current). The active ATM shelf adds further issuance optionality. Share count already grew 19.9% in 15 months.

6. U.S. government concentration. NGA, NRO, Space Force, and AFRL programs likely represent 40-50% of revenue (management has not disclosed precise customer concentration). A continuing resolution or budget sequestration is a non-trivial tail risk, even with management's claim that commercial imagery sits in dedicated budget lines.

7. Mission Solutions is destroying value. Q1 2026 revenue of $2.0M at approximately negative gross margins. No wind-down timeline provided. Every quarter this segment operates it dilutes consolidated gross margin and burns cash.

8. Luno B is not a protected moat. The NGA Luno B IDIQ is multi-vendor; individual delivery orders are subject to competitive bidding. The BULL's framing that Luno B carries 'no competitive risk' is incorrect — only the AFRL contract is sole-source.

9. Valuation prices in perfection. At 14.7x trailing P/S and approximately 11.2x forward P/S, the stock sits above the fair-value range implied by peer multiples. Jefferies downgraded to Hold in May 2026, citing space-sector enthusiasm over fundamentals. A guidance miss compresses the multiple sharply.

---

• The $30M one-year Assured contract — converted from a six-figure pilot in under six months — is the most important single data point in the thesis. It proves the land-and-expand model works at the top end; the question is whether the 'couple dozen' remaining pilots convert at anything like that speed.
• Operating cash flow improving through FY2024 (-$6.4M) then reversing sharply in FY2025 (-$28.3M) is a better leading indicator of the Gen-3 ramp's cash cost than the GAAP income statement, which is distorted by non-cash depreciation and derivative fair-value changes.
• The AFRL $99M sole-source IDIQ scope includes on-orbit AI processing and space domain awareness — this is pre-revenue optionality that positions Spectra AI for a next-generation capability layer, not just imagery analytics.
• No promotion signals detected. The stock's ~331% move appears driven by verifiable contract announcements and a guidance raise, not manufactured hype. The ainvest.com articles are uniformly bullish AI-generated content and should be discounted as independent research.
• The verifier identified a material error in the original bull-case framing: Luno B is multi-vendor, not sole-source. Only the AFRL contract is sole-source. This distinction matters for revenue assurance on the Luno B vehicle.

---

BlackSky is a genuine story — the technology works, the contracts are real, the subscription model has a defensible margin structure, and the demand environment (post-Ukraine ISR budgets, allied defense spending) is a legitimate structural tailwind. The bear case is not that the business is fake; it is that the stock at 14.7x trailing revenue has already bought the dream while the company is still several quarters away from demonstrating the H2 revenue acceleration the guidance requires.

The honest framing for a prospective observer: this is a bet that a pre-profitability defense-tech company with widening losses, deteriorating operating cash flow, and a $209M debt load successfully executes the sharpest revenue ramp in its public history — in H2 of a single calendar year — against a backdrop of lumpy government contracting, a whale competitor (Planet Labs) on a more advanced profitability trajectory, and a stock price that reflects optimism rather than current fundamentals per Jefferies. The subscription model inflection is real and if it executes, the long-term re-rating case is compelling. That is what the current price is paying for, and the margin of safety at these levels is thin.

---

*Research, not investment advice. Figures sourced from SEC filings and public data; verify before acting.*

Six institutional sell-side analysts cover BKSY (Jefferies, Oppenheimer, Canaccord among others per stockanalysis.com). No insider ownership data found in sources reviewed. Persistent equity dilution via ATM shelf and convertible note overhang indicates no buyback program; insiders are not demonstrably buying in the open market based on available disclosures. No promotion red flags detected.